Bermuda domiciled reinsurer PartnerRe has announced the appointment of Chris Shanahan as Chief Executive Officer (CEO) of its North American Life business.
Shanahan, currently President of US Life, will succeed outgoing CEO Alan Ryder, who is set to retire at the end of August this year.
Having joined PartnerRe in May 2018, Shanahan initially served as Executive Vice President, Corporate Development, US Life, before taking on his current President role in July 2019.
He has 25 years’ industry experience and previously worked as Executive Vice President, Mortality Solutions and Corporate Marketing at Hannover Re in the US.
At Hannover Re, he had overall responsibility for managing the traditional life reinsurance business, including business development, operations and marketing.
In his new role, Shanahan will be located in PartnerRe’s Charlotte, North Carolina office, and will report to Marc Archambault, CEO Life & Health.
“I am delighted that Chris has accepted the appointment to CEO, North America and I am confident that under his leadership our Canadian business will continue to thrive and that we will be successful in further developing our US franchise by delivering on our commitment to provide our clients with value, and shareholders with attractive returns,” said Archambault.
“Alan has had a very full and highly successful career in our industry,” he added. As an entrepreneur, he raised $500 million and launched Aurigen, a North American life reinsurance company which PartnerRe acquired in 2017.”
“For over a decade Alan has led what has become PartnerRe’s Life & Health operations in North America, developing a successful Canadian franchise and establishing our US platform for future long-term growth in the world’s largest Life reinsurance market.”
Concurrent with this change, André Piché, President for Life & Health Canada at PartnerRe, has been appointed CEO, Life & Health Canada, effective September 1, 2021.
He will continue to be responsible for the Canadian Life & Health business and will report to Shanahan.